Table 3

Cumulative incidence and progression of PFJOA and TFJOA and the inter-relationship

n (%)Crude OR (95% CI)Adjusted OR* (95% CI)
Cumulative incidence of PFJOA47/163 (28.8)
Stratified by severity of TFJOA at baseline
 None37/144 (25.7)11
 Mild TFJOA5/14 (35.7)3.2 (1.2 to 8.5)3.1 (1.2 to 8.4)
 Moderate/severe TFJOA5/5 (100)
Cumulative progression of PFJOA36/190 (18.9)
Stratified by severity of TFJOA at baseline
 None7/84 (8.3)11
 Mild TFJOA10/41 (24.4)4.1 (1.7 to 10.0)4.5 (1.8 to 11.2)
 Moderate/severe TFJOA19/65 (29.2)
Cumulative incidence of TFJOA55/253 (21.7)
Stratified by severity of PFJOA at baseline
 None23/144 (16.0)11
 Mild PFJOA24/84 (28.6)2.2 (1.2 to 4.0)2.2 (1.1 to 4.1)
 Moderate/severe PFJOA8/25 (32.0)
Cumulative progression of TFJOA23/91 (25.3)
Stratified by severity of PFJOA at baseline
 None2/14 (14.3)11
 Mild PFJOA13/41 (31.7)2.3 (0.5 to 10.9)1.7 (0.3 to 9.0)
 Moderate/severe PFJOA8/36 (22.2)
  • * Adjusted for gender, age, body mass index.

  • OA, osteoarthritis; PFJOA, patellofemoral joint osteoarthritis; TFJOA, tibiofemoral joint osteoarthritis.